​

Zimmer Biomet (ZBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZBH Stock Forecast

Zimmer Biomet (ZBH) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $96.33, with a high of $120.00 and a low of $83.00. This represents a 10.55% increase from the last price of $87.14.

$80 $91 $102 $113 $124 $135 High: $120 Avg: $96.33 Low: $83 Last Closed Price: $87.14

ZBH Stock Rating

Zimmer Biomet stock's rating consensus is Hold, based on 42 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (42.86%), 21 Hold (50.00%), 3 Sell (7.14%), and 0 Strong Sell (0.00%).

Hold
Total 42 0 3 21 18 Strong Sell Sell Hold Buy Strong Buy

ZBH Price Target Upside V Benchmarks

TypeNameUpside
StockZimmer Biomet10.55%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks32.91%

Price Target Trends

1M3M12M
# Anlaysts-520
Avg Price Target-$93.20$102.85
Last Closing Price$87.14$87.14$87.14
Upside/Downside-6.95%18.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2626171-26
May, 2626171127
Apr, 2626171127
Mar, 2636172129
Feb, 2627162128
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 29, 2026Truist Financial$92.00$80.8013.86%5.58%
Apr 29, 2026Canaccord Genuity$83.00$82.800.24%-4.75%
Apr 29, 2026Rick WiseStifel Nicolaus$105.00$82.8026.81%20.50%
Apr 29, 2026Robert W. Baird$92.00$82.8011.11%5.58%
Apr 29, 2026Matt MiksicBarclays$94.00$82.8013.53%7.87%
Feb 12, 2026Matt MiksicBarclays$100.00$96.693.42%14.76%
Feb 11, 2026UBS$89.00$93.69-5.01%2.13%
Jan 28, 2026UBS$86.00$85.270.86%-1.31%
Jan 09, 2026Bernstein$99.00$94.085.23%13.61%
Jan 09, 2026David RomanGoldman Sachs$93.00$94.08-1.15%6.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 29, 2026CitigroupNeutralNeutralhold
Apr 29, 2026BarclaysUnderweightUnderweighthold
Feb 20, 2026William BlairBuyMarket Performinitialise
Feb 12, 2026BarclaysUnderweightUnderweighthold
Feb 11, 2026UBSSellSellhold
Feb 11, 2026CitigroupBuyBuyhold
Jan 26, 2026Cowen & Co.HoldBuyupgrade
Jan 09, 2026BernsteinMarket PerformMarket Performhold
Jan 09, 2026Goldman SachsBuySelldowngrade
Jan 06, 2026Raymond JamesUnderperformMarket Performdowngrade

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.93$1.10$4.91$4.45$3.56---
Avg Forecast$7.17$6.84$7.51$7.98$8.56$9.24$9.99$10.61
High Forecast$7.28$6.90$7.57$8.01$8.82$11.87$10.76$10.73
Low Forecast$7.08$6.75$7.23$7.94$8.44$7.18$9.22$10.43
Surprise %-73.08%-83.92%-34.62%-44.24%-58.41%---

Revenue Forecast

$7B $7B $8B $8B $9B $10B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.83B$6.94B$7.39B$7.68B$8.23B---
Avg Forecast$7.86B$6.87B$7.38B$7.67B$8.01B$8.38B$8.78B$9.19B
High Forecast$7.95B$6.92B$7.43B$7.68B$8.08B$8.38B$8.81B$9.27B
Low Forecast$7.79B$6.80B$7.24B$7.66B$7.92B$8.37B$8.76B$9.07B
Surprise %-13.16%0.95%0.16%0.11%2.76%---

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$401.60M$231.40M$1.02B$903.80M$705.20M---
Avg Forecast$368.25M$224.98M$1.02B$1.67B$1.81B$2.00B$2.10B$2.22B
High Forecast$475.67M$307.13M$1.40B$1.68B$1.85B$2.49B$2.26B$2.25B
Low Forecast$260.83M$142.84M$651.48M$1.67B$1.77B$1.50B$1.93B$2.19B
Surprise %9.06%2.85%--45.98%-61.04%---

ZBH Forecast FAQ

Is Zimmer Biomet stock a buy?

Zimmer Biomet stock has a consensus rating of Hold, based on 42 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 21 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Zimmer Biomet is a neutral investment for most analysts.

What is Zimmer Biomet's price target?

Zimmer Biomet's price target, set by 42 Wall Street analysts, averages $96.33 over the next 12 months. The price target range spans from $83 at the low end to $120 at the high end, suggesting a potential 10.55% change from the previous closing price of $87.14.

How does Zimmer Biomet stock forecast compare to its benchmarks?

Zimmer Biomet's stock forecast shows a 10.55% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (32.91%).

What is the breakdown of analyst ratings for Zimmer Biomet over the past three months?

  • June 2026: 7.69% Strong Buy, 23.08% Buy, 65.38% Hold, 3.85% Sell, 0% Strong Sell.
  • May 2026: 7.41% Strong Buy, 22.22% Buy, 62.96% Hold, 3.70% Sell, 3.70% Strong Sell.
  • April 2026: 7.41% Strong Buy, 22.22% Buy, 62.96% Hold, 3.70% Sell, 3.70% Strong Sell.

What is Zimmer Biomet’s EPS forecast?

Zimmer Biomet's average annual EPS forecast for its fiscal year ending in December 2026 is $9.24, marking a 159.55% increase from the reported $3.56 in 2025. Estimates for the following years are $9.99 in 2027, and $10.61 in 2028.

What is Zimmer Biomet’s revenue forecast?

Zimmer Biomet's average annual revenue forecast for its fiscal year ending in December 2026 is $8.38B, reflecting a 1.78% increase from the reported $8.23B in 2025. The forecast for 2027 is $8.78B, and $9.19B for 2028.

What is Zimmer Biomet’s net income forecast?

Zimmer Biomet's net income forecast for the fiscal year ending in December 2026 stands at $2B, representing an 183.23% increase from the reported $705.2M in 2025. Projections indicate $2.1B in 2027, and $2.22B in 2028.